Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease

Multiple Sclerosis

Volumn 7, Issue 5, 2001, Pages 313-319

  Spitsin, S ^a   Hooper, D C ^a   Leist, T ^a   Streletz, L J ^a   Mikheeva, T ^a   Koprowski, H ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Autoimmunity; Demyelinating diseases; Encephalomyelitis; Inosine; Multiple sclerosis; Peroxynitrite; Uric acid

Indexed keywords

GADOLINIUM; INOSINE; PEROXYNITRITE; SCAVENGER; URIC ACID;

ADULT; ALLERGIC ENCEPHALOMYELITIS; ARTICLE; AUTOIMMUNITY; BACTERIUM; CLINICAL ARTICLE; CLINICAL TRIAL; DEGRADATION; DEMYELINATING DISEASE; DISEASE COURSE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG INACTIVATION; DRUG SAFETY; DRUG TOLERABILITY; EXPERIMENTAL MODEL; FEMALE; GASTROINTESTINAL TRACT; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PATHOGENESIS; SIDE EFFECT; URIC ACID BLOOD LEVEL;

ADMINISTRATION, ORAL; ADULT; FEMALE; GADOLINIUM; HUMANS; INOSINE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; PEROXYNITROUS ACID; URIC ACID;

EID: 0034747982     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245801681138013     Document Type: Article

References (22)

1. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
2. -: Implications for the treatment of multiple sclerosis
3. Peroxynitrite formation within the central nervous system in active multiple sclerosis
4. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry
5. Protection against peroxynitrite-dependent tyrosine nitration and α1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants
6. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis
7. Correlation between urate level and clinical course of multiple sclerosis
8. Uric acid levels in patients with multiple sclerosis: Analysis in mono- and dizygotic twins
9. Induction of creatininase activity in chronic renal failure: Timing of creatinine degradation and effect of antibiotics
10. Uric acid levels in sera from patients with multiple sclerosis
11. Origin and extrarenal elimination of uric acid in man
12. The elimination of uric acid in man by means of C-14 labeled uric acid. Uricolysis
13. Degradation of purines and pyrimidines by microorganisms
14. Inosine supplementation has no effect on aerobic or anaerobic cycling performance
15. Effect of inosine supplementation on aerobic and anaerobic cycling performance
16. Studies regarding some effects of inosine in elite weightlifters
17. 2 peak
18. Therapeutic effect of inosine in Tourette syndrome and its possible mechanism of action
19. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis
20. Ascorbate concentration in human cerebrospinal fluid (CSF) and serum. Intrathecal accumulation and CSF flow rate
21. Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis
22. Multiple sclerosis